“This is a paradigm shift away from the old model of academic institutions focusing solely on basic science ... AWRI’s Centre for Gene Therapy was founded in 2002 — a time when gene therapy ...

The global gene therapy market size was valued at USD 6.30 billion in 2024 and is projected to reach from USD 7.47 billion in ...

And, despite the pandemic, 2020 was a landmark year for the 24-year-old, from County Durham, who became the first person in the UK to receive a revolutionary new gene therapy on the NHS.

The therapy is a critical treatment option for various life-threatening disease. Earlier, GST on gene therapy was set at 12 ...

Nakai said this research provides valuable insights into how to optimize AAV-based gene delivery to the kidney in both basic research and gene therapy. It shows that the best results come not just ...

Gene therapy has been available since 2022 for hemophilia B and since 2023 for hemophilia A, yet some major medical institutions have barely treated any patients so far. What’s the holdup?

Researchers are making strides in improving gene therapies for genetic diseases, particularly chronic kidney disease, using adeno-associated virus, or AAV, vectors. While AAV-based treatments have ...

More information: Taisuke Furusho et al, Enhancing gene transfer to renal tubules and podocytes by context-dependent selection of AAV capsids, Nature Communications (2024). DOI: 10.1038/s41467-024 ...